Tapering Bupropion XL 150 mg Daily
For patients on bupropion XL 150 mg once daily, no tapering is necessary—the medication can be discontinued abruptly without dose reduction. 1
FDA-Approved Discontinuation Protocol
The FDA label for bupropion XL provides clear guidance on discontinuation:
- Patients on 150 mg once daily: Discontinue directly without tapering 1
- Patients on 300 mg once daily: Reduce to 150 mg once daily before discontinuation 1
Since you are taking 150 mg daily (the lower dose), you fall into the first category and can stop the medication without a gradual taper.
Why Tapering Is Not Required at This Dose
Bupropion does not cause physical dependence or significant withdrawal syndromes at therapeutic doses. 1 Unlike benzodiazepines, opioids, or SSRIs, bupropion's mechanism of action (norepinephrine and dopamine reuptake inhibition) does not typically produce withdrawal symptoms requiring gradual dose reduction at standard doses. 2, 3
The FDA specifically distinguishes between the 150 mg and 300 mg doses, recommending tapering only for the higher dose—this indicates that 150 mg is considered safe for abrupt discontinuation. 1
What to Monitor After Discontinuation
While tapering is not required, you should be aware of potential issues:
- Return of underlying symptoms: If bupropion was treating depression, ADHD, or other conditions, the original symptoms may re-emerge over days to weeks 1, 3
- Mood changes: Monitor for worsening depression, anxiety, or irritability—these typically reflect the underlying condition rather than withdrawal 1
- Rare discontinuation effects: Some patients report mild, transient symptoms like headache or mood changes, but these are uncommon at 150 mg 1
Clinical Context
The evidence base supports straightforward discontinuation at your dose. Studies evaluating bupropion XL in depression and ADHD did not identify significant withdrawal syndromes requiring tapering protocols. 4, 5, 6 The drug's pharmacokinetic profile (half-life of approximately 21 hours for bupropion and longer for active metabolites) provides gradual clearance even with abrupt cessation. 2, 7
If you have concerns about stopping or experience significant symptom changes after discontinuation, contact your prescribing physician to discuss whether resuming treatment or addressing underlying conditions is appropriate.